Wound scarring and contracture is an important clinical problem with potentially serious consequences for the surgical or burn patient, including impairment of normal tissue regeneration and neighboring tissue function. The scarring that is a hallmark of normal wound healing occurs as a consequence of finely regulated interactions between fibroblasts cytokines, growth factors, proteases and extracellular matrix molecules. The long term goal is to understand this regulatory mechanism and develop new therapies to control scarring. The fibronectins (FNs), present in low levels in most normal tissues, are adhesive glycoproteins that mediate important functions, in vitro, such as cell activation, proliferation and migration. The investigators demonstrate that a dramatic increase in the levels of FNs occurs at the wound site, first by extravasation of plasma FN from blood, and then from synthesis by wound cells, making FNs as prominent components of the wound matrix. Two alternatively spliced segments, termed EIIIA or EIIIB, included in certain FN variants are expressed prominently in FNs present during embryogenesis. These two segments are missing from normal plasma FN and are present at low levels in most normal adult tissues. They find that expression by wound cells of FN variants that include the EIIIA and EIIIB segments is dramatically upregulated following injury in a characteristic spatial and temporal pattern. Moreover, parallel patterns of EIIIA+FNs and SMC a-actin expression occur during cutaneous wound healing. These findings suggest that the FN-containing wound matrix supplies a critical regulatory function in governing wound cell function. Indeed, when tested in vitro, FN variants that include the EIIIA segment activate fibroblasts to express increased levels of SMC a-actin. The specific hypothesis of the present proposal states that adhesion of fibroblasts to the EIIIA segment of FN provides a key signal, which together with cytokines like TGF-b, regulate the activity of fibroblasts during scar formation.
Two specific aims are proposed to test this hypothesis: (1) To determine the structural features within EIIIA+FNs that regulate fibroblasts functions; (2) To analyze specific fibroblast functions regulated by EIIIA+FNs.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM056442-03
Application #
6019355
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Program Officer
Moshell, Alan N
Project Start
1997-08-01
Project End
2000-07-31
Budget Start
1999-08-01
Budget End
2000-07-31
Support Year
3
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Varney, Scott D; Betts, Courtney B; Zheng, Rui et al. (2016) Hic-5 is required for myofibroblast differentiation by regulating mechanically dependent MRTF-A nuclear accumulation. J Cell Sci 129:774-87
Shinde, Arti V; Kelsh, Rhiannon; Peters, John H et al. (2015) The ?4?1 integrin and the EDA domain of fibronectin regulate a profibrotic phenotype in dermal fibroblasts. Matrix Biol 41:26-35
Oliver-Kozup, Heaven; Martin, Karen H; Schwegler-Berry, Diane et al. (2013) The group A streptococcal collagen-like protein-1, Scl1, mediates biofilm formation by targeting the extra domain A-containing variant of cellular fibronectin expressed in wounded tissue. Mol Microbiol 87:672-89
Wang, Xiaobo; Hu, Guoqing; Betts, Courtney et al. (2011) Transforming growth factor-?1-induced transcript 1 protein, a novel marker for smooth muscle contractile phenotype, is regulated by serum response factor/myocardin protein. J Biol Chem 286:41589-99
Singh, Purva; Chen, Chun; Pal-Ghosh, Sonali et al. (2009) Loss of integrin alpha9beta1 results in defects in proliferation, causing poor re-epithelialization during cutaneous wound healing. J Invest Dermatol 129:217-28
Shinde, Arti V; Bystroff, Christopher; Wang, Chunyu et al. (2008) Identification of the peptide sequences within the EIIIA (EDA) segment of fibronectin that mediate integrin alpha9beta1-dependent cellular activities. J Biol Chem 283:2858-70
Dabiri, Ganary; Tumbarello, David A; Turner, Christopher E et al. (2008) TGF-beta1 slows the growth of pathogenic myofibroblasts through a mechanism requiring the focal adhesion protein, Hic-5. J Invest Dermatol 128:280-91
Dabiri, Ganary; Tumbarello, David A; Turner, Christopher E et al. (2008) Hic-5 promotes the hypertrophic scar myofibroblast phenotype by regulating the TGF-beta1 autocrine loop. J Invest Dermatol 128:2518-25
Meckmongkol, Teerin T; Harmon, Robert; McKeown-Longo, Paula et al. (2007) The fibronectin synergy site modulates TGF-beta-dependent fibroblast contraction. Biochem Biophys Res Commun 360:709-14
Dabiri, Ganary; Campaner, Anelisa; Morgan, Jeffrey R et al. (2006) A TGF-beta1-dependent autocrine loop regulates the structure of focal adhesions in hypertrophic scar fibroblasts. J Invest Dermatol 126:963-70

Showing the most recent 10 out of 16 publications